Metropolitan Life Insurance CO Cogent Biosciences, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$4.38 - $9.02 $705 - $1,452	161 Added 4.88%	3,461 $23,000
Q4 2023 Feb 14, 2024	SELL	$4.06 - $10.08 $5,805 - $14,414	-1,430 Reduced 30.23%	3,300 $19,000
Q3 2023 Nov 14, 2023	BUY	$9.69 - $13.34 $11,356 - $15,634	1,172 Added 32.94%	4,730 $46,000
Q2 2023 Aug 10, 2023	BUY	$9.85 - $13.24 $35,046 - $47,107	3,558 New	3,558 $42,000
Q4 2022 Jun 14, 2023	BUY	$10.65 - $14.84 $41,077 - $57,237	3,857 New	3,857 $44.6 Million
Q3 2022 Jun 14, 2023	BUY	$9.39 - $16.99 $36,217 - $65,530	3,857 New	3,857 $57.5 Million
Q3 2022 Mar 30, 2023	BUY	$9.39 - $16.99 $11,437 - $20,693	1,218 Added 46.15%	3,857 $57,000
Q3 2022 Nov 14, 2022	BUY	$9.39 - $16.99 $11,437 - $20,693	1,218 Added 46.15%	3,857 $58,000
Q2 2022 Jun 20, 2023	BUY	$3.92 - $9.73 $10,344 - $25,677	2,639 New	2,639 $23,000
Q1 2022 Jun 20, 2023	BUY	$5.31 - $8.7 $14,013 - $22,959	2,639 New	2,639 $19,000
Q1 2022 Mar 30, 2023	SELL	$5.31 - $8.7 $42,543 - $69,704	-8,012 Reduced 75.22%	2,639 $19,000
Q1 2022 May 12, 2022	SELL	$5.31 - $8.7 $42,543 - $69,704	-8,012 Reduced 75.22%	2,639 $20,000
Q4 2021 Jun 21, 2023	BUY	$7.51 - $10.81 $79,989 - $115,137	10,651 New	10,651 $91,000
Q4 2021 Mar 30, 2023	BUY	$7.51 - $10.81 $315 - $454	42 Added 0.4%	10,651 $91,000
Q4 2021 Feb 15, 2022	BUY	$7.51 - $10.81 $315 - $454	42 Added 0.4%	10,651 $91,000
Q3 2021 Jun 21, 2023	BUY	$5.99 - $9.14 $63,547 - $96,966	10,609 New	10,609 $89,000
Q3 2021 Mar 30, 2023	BUY	$5.99 - $9.14 $40,444 - $61,713	6,752 Added 175.06%	10,609 $89,000
Q3 2021 Nov 15, 2021	BUY	$5.99 - $9.14 $63,547 - $96,966	10,609 New	10,609 $89,000

Others Institutions Holding COGT

# of Institutions

170

Shares Held

113M

Call Options Held

56.7K

Put Options Held

40.4K

Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

10.5M
Shares

$93.2 Million
0.31% of portfolio
Kynam Capital Management, LP Princeton, NJ

9.24M
Shares

$82.2 Million
8.19% of portfolio
Commodore Capital LP New York, NY

7.54M
Shares

$67.1 Million
6.92% of portfolio
Black Rock Inc. New York, NY

7.29M
Shares

$64.9 Million
0.0% of portfolio
Tcg Crossover Management, LLC Palo Alto, CA

6.96M
Shares

$62 Million
9.76% of portfolio

View Full List

About Cogent Biosciences, Inc.

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $585M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

More about COGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account